DMD # 67827 one of the main causes of subclinical endotoxemia as well as sepsis (Proctor, 2001; Brenchley et al., 2006; Douek, 2007; Silva and dos Santos Sde, 2013) . Indeed, while the use of ART is associated with decreased circulating levels of LPS, levels are still higher in HIV patients than non-infected individuals (Mehandru et al., 2006; Marchetti et al., 2008; d'Ettorre et al., 2011; Jenabian et al., 2015) .
Infection induced inflammation has been shown to alter the disposition of drugs. Proinflammatory cytokines including IL-6, TNF-α, IL-1β have been frequently reported to decrease the expression and function of ABC and SLC transporters and Cytochrome P450 (CYP) metabolising enzymes (Piquette-Miller et al., 1998; Tang et al., 2000; Kalitsky-Szirtes et al., 2004; Wang et al., 2005; Englund et al., 2007; Petrovic et al., 2008) . Studies in HIV infected individuals have also reported altered expression of drug metabolizing enzymes and transporters. One study reported that HIV infected individuals who are not on anti-retroviral therapy (ART naïve), had lower CYP3A4 and CYP2D6 enzymatic activity compared with uninfected individuals, which correlated with increased plasma cytokine level (Jones et al., 2010) . More recently, ART naïve HIV patients were found to have significantly lower P-glycoprotein (P-gp/ ABCB1) and Multidrug resistance-associated protein 2 (MRP2/ABCC2) protein levels in the rectal-sigmoid colon compared with non-infected subjects (De Rosa et al., 2013) . In addition, in vitro incubation of cells with the HIV gp120 viral protein has been found to increase proinflammatory cytokines IL-6, IL-1β and TNF-α as well as decrease the expression and function of P-gp in rat and human brain astrocytes (Ronaldson and Bendayan, 2006; Ashraf et al., 2011) . Due to dysregulation of the immune system, it is plausible that infection-induced inflammatory responses may be potentiated in HIV patients (da Silva et DMD # 67827 6 al., 1999; Nguyen and Biron, 1999; Lester et al., 2008; Lester et al., 2009; Bukh et al., 2011) . We hypothesize that augmented inflammatory responses in response to coinfections could lead to further downregulation in the expression of transporters and drug metabolising enzymes. As many of the anti-retroviral agents are substrates of drug transporters and metabolizing enzymes, understanding their regulation in HIV patients is important in maintaining therapeutic drug levels and predicting potential drug-disease interactions. Moreover, protease inhibitors; an integral part of combination ART, are potent inducers/inhibitors of drug transporters and metabolising enzymes which increases the risk of drug-drug interactions in these patients (Gutmann et al., 1999; Sulkowski et al., 2000; Kim, 2003; Klaassen and Aleksunes, 2010; Griffin et al., 2011) . Indeed, the existence of co-infections and alterations in drug metabolism is known to increase the risk of ART-associated liver damage in HIV patients (Sulkowski et al., 2000; Soriano et al., 2008; Puoti et al., 2009) .
In this study we examined the impact of endotoxin-mediated inflammation on the expression of drug transporters and metabolising enzymes in HIV-1 transgenic (HIV-Tg) rats. The HIV-Tg rat model is a non infectious small animal model of HIV, expressing all of the HIV-1 viral proteins except for the replication gag and pol genes (Reid et al., 2001; Hatziioannou and Evans, 2012) . This makes the model useful for demonstrating effects of HIV viral proteins in the absence of viral replication which shares similarity with HIV patients given ART; as there is no viral replication, yet persistent inflammation (Chang et al., 2007a; Chang et al., 2007b; Homji et al., 2012) . As the rats age, progressive illness that shares many similarity with HIV infected humans become apparent. This includes pneumonitis, neurological deficits, wasting, respiratory difficulty, cardiac abnormalities DMD # 67827 7 and renal disease (Ray et al., 2003; Peng et al., 2010) . Immune dysregulation is also evident including impaired macrophage phagocytic function (Joshi and Guidot, 2011) , defects in T helper 1 immune responses (Reid et al., 2001; Reid et al., 2004; Yadav et al., 2006; Royal et al., 2012) and defective leukocyte endothelial adhesion (Chang et al., 2007b) . Increased cytokine levels have been found in liver and brain tissue lysates (Joshi and Guidot, 2011; Royal et al., 2012) . In response to endotoxin administration, the HIVTg rats have previously demonstrated augmented inflammatory response (Chang et al., 2007a; Chang et al., 2007b) , similar to that seen in HIV (+) individuals (Lester et al., 2008; Bukh et al., 2011) . Care and provided with ad libitum food and water on a 12 h light/dark schedule. Three month old male and female HIV-Tg or same generation WT littermates were given an intraperitoneal injection of either 5 mg/kg Lipopolysaccharide (LPS, E.coli 055:B5, Sigma-Aldrich, Oakville, ON) or saline. Rats (n=7-9 per group) were sacrificed 18 hours following injection and serum and tissues collected and snap-frozen with liquid nitrogen and stored at -80°C until analysis. We have previously observed significant endotoxinmediated changes in the expression of numerous drug transporters in rats at various times between 6 to 24 hours after endotoxin administration (Wang et al., 2005; Petrovic et al., 2008) . As significant changes in mRNA with corresponding changes in protein expression were generally seen at 18 hours post injection in previous studies, we therefore examined the impact of endotoxin in HIV-Tg and WT rats at 18 hours postinjection.
Serum and Tissue analysis:
Serum cytokine concentrations were measured via commercially available rat specific ELISA kits (R&D Systems, Minneapolis, MN) according to manufacturer's instructions.
Minimum detectable levels for IL-6, IL-1β, TNF-α and interferon (IFN)-γ were 36, 5, 9 This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on March 14, 2016 as DOI: 10.1124 at ASPET Journals on October 13, 2017 dmd.aspetjournals.org Downloaded from and 10 pg/mL, respectively. Total bile acid concentrations were measured in the serum and in 100 g of liver homogenate using a Rat Total Bile acid Kit (Crystal Chem Inc., Downers Grove, IL) according to manufacturer's instructions and as previously described (Ghoneim et al., 2015) . Alanine aminotransferase (ALT) activity in the serum was measured following manufacturer instructions (Sigma-Aldrich, St. Louis, MO) and results were reported as milliunit/mL where one milliunit (mU) of ALT is defined as the amount of enzyme that generates 1 nmole of pyruvate/min at 37 °C.
Quantitative Real-time Polymerase Chain Reaction:
Total RNA was extracted from around 50 mg of frozen tissue using the TRIzol extraction method (Invitrogen, Carlsbad, CA) according to manufacturer instructions. RNA concentration was measured using NanoDrop spectrophotometer (Thermo Fisher Sceintific,Waltham, MA) and 2 μ g of RNA was then treated with Deoxyribonuclease I (DNaseI) ( Invitrogen, Carlsbad, CA) and reverse transcribed (RT) with High Capacity cDNA RT kit (Applied Biosystems, Foster City, CA). Real-time quantitative PCR was carried out for triplicate samples of genomic cDNA specific for each primer set (Supplemental Table 1 ) and performed using Power SYBR Green detection system (ABI HT 7900, Applied Biosystems, Streetsville, ON, Canada). A comparative Ct (ΔΔCt) method was used to calculate relative mRNA expression of each gene of interest normalized to house keeping gene β-actin. Similar results were obtained using GAPDH or cyclophilin as housekeeping genes.
Western Blotting:
This article has not been copyedited and formatted. The final version may differ from this version. Isolation of crude membrane fractions has been previously described (Petrovic and Piquette-Miller, 2010) . Briefly 0.3 g of liver tissue was homogenized in lysis buffer containing 0.1M Tris-HCL, 3μL/mL Protease inhibitor and 50μg/mL phenylmethylsulfonyl fluoride, centrifuged (30 000g for 1hour) and quantified using the Bradford Assay. 40μg of protein was separated by SDS-polyacrylamide gel electrophoresis and transferred to PVDF membranes (Bio-rad laboratories, Mississauga, Canada). Membranes were blocked using 5% skim milk and incubated with the following primary antibodies: P-gp ABCB1 C219 1:500 (Enzo Life Sciences, Farmingdale, NY), ABCC2 M2 III-5 1:50 (Abcam Inc., Cambridge, MA) and Equilibrative Nucleoside Transporter 1 (ENT1 /SLC29A1) F-12 1:100 (Santa-Cruz Biotech, Dallas, Texas).
Following a series of washing, membranes were incubated with secondary anti-mouse antibody 1:3000 (Jackson ImmunoResearch Laboratories, West Grove, PA).
Immunodetectable protein was detected using SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, lL) and band density was quantified using Alpha Ease FC imaging software (Alpha Innotech). β-actin AC-15 1:10000 (Sigma-Aldrich, Oakville, ON) was used to control for loading variability and a calibrator sample for each gender was used to control for different gels. Mouse heart tissue extract was used as a positive control for Ent1.
Genotyping:
Genotyping was performed by PCR amplification of viral proteins (gp120, tat, vif, nef) using 0.5g of spleen tissue and PCR products were separated by gel electrophoresis.
Separation was carried on a 2% agarose gel in 1x TBE, 6x loading dye using Fast start This article has not been copyedited and formatted. The final version may differ from this version. 
Statistical analysis:
Statistical analysis was performed in GraphPad Prism 6 using a One-way ANOVA, followed by Fisher's Least Significant Difference test to compare the effect of endotoxin administration in WT and HIV-Tg rats where males and females were analyzed separately and data was expressed as a fold change from WT saline injected animals for each gender. One-way ANOVA, followed by Fisher's Least Significant Difference test was also used to determine differences in basal gene expression between males and females in WT and HIV-Tg rats where results were compared relative to male WT saline injected animals. A Student's T-test was used to compare cytokine levels following endotoxin administration between WT and HIV-Tg rats as serum levels were undetectable in saline injected animals.
This article has not been copyedited and formatted. The final version may differ from this version. 
Basal hepatic gene expression in the liver
The basal hepatic expression of most ABC and SLC transporters and nuclear receptors were not significantly different between HIV-Tg and WT (Table 1 ). The expression of Cyp3a2 was 62% lower in male HIV-Tg rats compared with WT while Cyp3a9, Slc10a1 and Abcb11 was (25-54%) lower in female HIV-Tg compared with WT littermates.
Hepatic mRNA levels of TNF-α and iNOS were slightly but significantly higher in saline treated female HIV-Tg as compared to WT (Table 1) .
Gender differences in metabolic enzymes and drug transporter expression
Gender differences were detected in both HIV-Tg and WT saline controls (Table 1) . A 250 fold higher expression of Cyp3a2 enzyme was detected in WT males as compared to females and a 14 fold higher expression of Cyp3a9 enzyme was detected in female WT as compared with males. With regards to hepatic transporters, 1.5 to 4 fold higher mRNA levels of Abcb1a, Abcb11, Abcc3, Slco1b2, Slc10a1 and Slc22a1 were detected in female WT as compared to males. Similar findings were seen in HIV-Tg rats. 
Inflammatory response to endotoxin
Pro-inflammatory cytokines were examined as a measure of systemic and local inflammatory responses to endotoxin administration. While serum levels of the proinflammatory cytokines were below the detection limit in saline treated HIV-Tg and WT, a significant endotoxin-mediated induction of IL-6, IL-1β, TNF-α and IFN-γ was observed in the serum of both control WT and HIV-Tg rats (Table 2) Figure 3B ). The protein expression of P-gp was significantly downregulated in endotoxin-treated HIV-Tg and WT male rats and in female HIV-Tg but not WT rats ( Figure 2B ). Moreover, Ent1 protein levels were significantly lower only in HIV-Tg rats ( Figure 6B ). A significant negative correlation (P<0.05) was found between TNF-α and Abcg2, Abcc2, Abcb11, Cyp3a2, Slco1a1, Slco1a1, Slco1b2, Slc22a1, Slco29a1, Slc10a1 as well as between IL-1β and Abcb1a, Abcg2, Abcc2, Abcb11, Cyp3a2, Slco1a1, Slco1a1, Slco1b2, Slc22a1, Slco29a1, Slc10a1 and between iNOS and Abcb1b, Abcg2, Abcb11, Slco1a1, Slco1a1, Slco1b2, Slc22a1, Slco29a1 (Supplemental Table 2 ).
Biochemical changes in response to endotoxin
As the expression of several bile acid transporters as well as Cyp7a1 were altered in the endotoxin-treated groups, we examined the impact on serum and hepatic concentrations of total bile acids (Table 3) . Endotoxin resulted in a significant increase in serum total bile acid concentrations in the HIV-Tg but not WT rats. Intra-hepatic concentrations of total bile acids were significantly increased in endotoxin treated HIV-Tg and WT male but not female rats. Alanine transaminase activity, which is a measure of liver toxicity, was significantly increased in the serum of endotoxin-treated HIV-Tg groups but not the WT groups (Table 3) . This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion:
Despite the use of ART, HIV patients often encounter bacterial endotoxin infections either as opportunistic infections or from microbial translocation. This adds to the state of inflammation and immune activation (Hazenberg et al., 2003; Brenchley et al., 2006; Appay and Sauce, 2008; Mogensen et al., 2010) . The HIV-Tg rat has demonstrated augmented inflammatory response to endotoxin similar to that observed in HIV patients (Chang et al., 2007a; Chang et al., 2007b; Lester et al., 2008; Bukh et al., 2011) . In addition, HIV viral proteins have been shown to contribute to inflammation altered expression and function of drug transporters. As endotoxin-mediated effects on the expression of hepatic gene expression is commonly examined in rodents (Piquette-Miller et al., 1998; Tang et al., 2000; Cherrington et al., 2004; Kalitsky-Szirtes et al., 2004; Wang et al., 2005; Petrovic et al., 2008) , and similar endotoxin-mediated effects on the expression and activity of drug metabolizing enzymes are seen in humans and rodents (Shedlofsky et al., 1994; Shedlofsky et al., 1997) , we examined whether immunological changes associated with the expression and activity of HIV viral proteins would impact endotoxin-mediated effects in HIV-Tg rats.
At the basal level, the HIV-Tg rat demonstrated significantly lower gene expression of drug metabolising enzymes Cyp3a2 and Cyp3a9 in male and female rats respectively.
Decreased enzymatic activity of CYP3A4 and CYP2D6 has been previously reported in HIV infected individuals and correlated with increased plasma cytokine level (Jones et al., 2010) . While serum concentrations and basal expression of the pro-inflammatory cytokines were relatively unchanged in the HIV-Tg, it is possible that other factors including oxidative stress may play a role. HIV viral proteins gp120 and tat are known to This 
at ASPET Journals on October 13, 2017 dmd.aspetjournals.org Downloaded from induce oxidative stress markers (Nicolini et al., 2001; Walsh et al., 2004; Price et al., 2005) . Indeed there was a significant elevation in the mRNA level of inducible nitric oxide (iNOS) and TNF-α in female HIV rats compared with WT. This could partially explain the reduction in Cyp3a expression as several studies suggest the involvement of nitric oxide in downregulating CYP 450 enzyme (Carlson and Billings, 1996; Donato et al., 1997; Aitken et al., 2008) . Likewise, Abcb11 and Slc10a1 were significantly lower in female HIV-Tg rats. In general apart from these differences, HIV-Tg rats displayed similar basal expression of most hepatic drug transporters relative to their WT littermates.
Changes in the expression of Abcb1a and Abcc1 have also been reported in 24 but not 8 week old HIV-Tg rats (Robillard et al., 2014) . As 5 fold higher mRNA levels of gp120 were seen in the livers of the 24 week as compared to 8 week old rats, it is likely that we did not observe similar changes due to the age difference in our study. Differences in HIV-Tg associated inflammation are seen within the literature. While we did not detect measurable levels of cytokines in the serum of our HIV-Tg rats. Chang, et al observed a significant elevation of serum IL-1β in 5 month old HIV-Tg rats (Chang et al., 2007a) .
On the other hand, Homji, et al did not detect changes in serum levels of IL-1β and TNF-α in 5 month old HIV-Tg (Homji et al., 2012) . (Shedlofsky et al., 1997; Piquette-Miller et al., 1998; Cherrington et al., 2004; Aitken et al., 2006; Cressman et al., 2012) . Reduced expression and activity of nuclear receptor PXR has also been linked to these inflammation-mediated changes (Teng and Piquette-Miller, 2008) . While changes in transporter expression in response to endotoxin administration in our study are transient due to the acute nature of the inflammatory stimulus, more persistent changes are likely to occur if inflammation becomes chronic and is not successfully resolved.
As compared to WT, the administration of endotoxin to HIV-Tg rats was associated with a profound and augmented inflammatory response. This suggests that the immune response is altered in these animals despite the absence of physical signs of disease.
Likewise, previous studies have also reported exacerbated responses to endotoxin in older HIV-Tg rats (Chang et al., 2007a; Chang et al., 2007b) . Consistent with the observed inflammatory response, we detected a significant endotoxin-mediated downregulation in the hepatic expression of numerous ABC and SLC transporters in addition to metabolic enzymes in the HIV-Tg rats. Of note, while we observed a higher induction of inflammatory markers in the endotoxin-treated HIV-Tg rats, the degree of gene downregulation was generally similar in the HIV-Tg and WT groups. This is likely due to maximum inhibition occurring in both groups in response to dose of LPS used. Indeed, a 80-90% reduction in hepatic expression was seen for most genes in both endotoxin treated groups. A maximal downregulation of hepatic transporters expression after cytokine exposure has been previously reported. In vitro studies in human hepatocytes This article has not been copyedited and formatted. The final version may differ from this version. Of particular interest was our finding that endotoxin administration imposed a more pronounced downregulation of Ent1 (Slc29a1) in the HIV-Tg rat. The nucleoside transporter Ent1 is the primary transporter for the nucleoside inhibitor ribavirin (Jarvis et al., 1998) . Ribavirin is commonly prescribed in patients with hepatitis C (HCV) and is reported to be less effective in the presence of HIV/HCV co-infections (Carrat et al., 2004; Torriani et al., 2004; Price and Thio, 2010) . While the antiviral mechanism of ribavirin for the treatment of HCV is not clearly understood (Hofmann et al., 2008) , it has been suggested that the therapeutic response to ribavirin is dependent on its uptake into hepatocytes (Ibarra and Pfeiffer, 2009; Iikura et al., 2012) . Our results, which demonstrate a pronounced downregulation of this nucleoside transporter in an HIV model of bacterial co-infection could provide some insight into the decreased effectiveness in HIV/HCV patients. To this point, ENT1 genetic polymorphisms has been shown to influence the virological response to ribavirin therapy in HIV/HCV and HCV patients possibly due to modulated ribavirin uptake into hepatocytes (Morello et al., 2010; Iikura et al., 2012; Tsubota et al., 2012) .
It is well documented that endotoxin administration can decrease bile acid dependent and independent flow in a process that is believed to occur due to inhibited transport of bile salts and organic anions on the sinusoidal and canalicular membranes of hepatocytes (Moseley et al., 1996; Bolder et al., 1997; Cherrington et al., 2004; Geier et al., 2007) . While the extent of change in the bile acid transporters following endotoxin exposure were not very different between wild-type and HIV-Tg, a dramatic increase in total bile acids was present in the serum of HIV-Tg following endotoxin. It is plausible that the augmented increase in serum bile acids in the HIV-Tg rats results from combined changes in multiple transporters rather than through a single transport mechanism.
Moreover, intra-hepatic bile concentrations were increased following endotoxin administration in both WT and HIV-Tg male rats. While we did not detect differences in hepatic bile acid concentration solely as a result of HIV; the presence of co-existing infections is considered a frequently encountered cause of cholestasis in HIV individuals (Te, 2004) . Moreover, abnormal liver enzymes are common among HIV infected individuals and are predisposed by medication toxicity from anti-retroviral drug therapy as well as the presence of co-infections (Price and Thio, 2010) . Administration of bacterial endotoxin clearly elevated ALT activity in the serum of HIV-Tg rats more so than in WT which confirms that the presence of co-infections does increase the risk of hepatotoxicity in the presence of HIV viral proteins.
Gender differences in the expression of drug transporters and metabolic enzymes were detected in our study in both HIV-Tg and WT rats. We observed significantly higher hepatic expression of several transporters in females. A higher hepatic expression of Mdr1 in female rats has been previously reported (Piquette-Miller et al., 1998; Salphati and Benet, 1998) which is contrary to what is reported in humans (Schuetz et al., 1995; Yang et al., 2012) . On the other hand, Cyp3a2 expression was dramatically higher in male rats, while Cyp3a9 expression was more predominant in females . This is in agreement with other studies which have described Cyp3a9 and Cyp3a62 as the predominant Cyp3a isoform in females (Salphati and Benet, 1998; Matsubara et al., 2004) . Gender differences in responses to ART have been observed and it has been suggested that these differences may be linked to gender differences in drug transporter and/or CYP expression (Ofotokun, 2005) . While this has not been examined or confirmed in vivo, it is plausible that gender differences in gene regulation could contribute to reported differences in therapeutic response to ART.
In conclusion, we demonstrated that endotoxin imposes a pronounced downregulation of numerous hepatic transporters and metabolic enzymes in HIV-Tg rats. Our findings suggest that heptobiliary clearances of endogenous and exogenous substrates are altered in the HIV-Tg rat after endotoxin exposure. This is particularly important for drugs that are highly dependent on both metabolism and transporter-mediated processes such as protease inhibitors (Choo et al., 2000; Huisman et al., 2000; Griffin et al., 2011) . This is Representative gels are shown below. This article has not been copyedited and formatted. The final version may differ from this version. 
